Patents by Inventor Michel Mouren

Michel Mouren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5024828
    Abstract: Novel isomers or mixtures of isomers of radioactive pyrethrinoids marked with iodine of the formula ##STR1## wherein X.sub.1 is selected from the group consisting of halogen and --CF.sub.3, X.sub.2 is a halogen, R is the residue of an amino acid of the formula R--NH.sub.2 or a derivative thereof containing an iodine acceptor group and marked with iodine.sup.125 or iodine.sup.131, process for their preparation and intermediates and their use in radioimmunological determination.
    Type: Grant
    Filed: January 28, 1987
    Date of Patent: June 18, 1991
    Assignee: Roussel Uclaf
    Inventors: Jean-Pierre Demoute, Gaetan Touyer, Michel Mouren
  • Patent number: 4661295
    Abstract: Novel radioactive estradienes labelled with tritium of the formula ##STR1## wherein .sup.3 H is tritium and R is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and acyl of an organic carboxylic acid of 1 to 10 carbon atoms and the study and radioimmunological determination of non-radioactive 11.beta.-(4-dimethylaminophenyl)-17.alpha.-(prop-1-ynyl)-.DELTA..sup.4,9 -estradiene-17.beta.-ol-3-one and its metabolites in biological fluids and novel intermediates.
    Type: Grant
    Filed: June 14, 1984
    Date of Patent: April 28, 1987
    Assignee: Roussel Uclaf
    Inventors: Alain Jouquey, Jean-Noel Veltz, Jean Salmon, Michel Mouren
  • Patent number: 4639336
    Abstract: Novel radioactive estradienes labelled with iodine of the formula ##STR1## in the form of their syn or anti isomers or mixtures thereof wherein the wavy line indicates anti or syn position, R is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and acyl of an organic carboxylic acid of 1 to 12 carbon atoms and R.sub.1 is the residue of an amino acid R.sub.1 NH.sub.2 possessing an iodine acceptor group or a derivative thereof labelled with iodine .sup.125 or .sup.131 and their preparation and novel intermediates, antigens prepared from the compounds of formula I and bovine seric albumin or human seric albumin and their preparation and their use for the preparation of antibodies.
    Type: Grant
    Filed: June 14, 1984
    Date of Patent: January 27, 1987
    Assignee: Roussel Uclaf
    Inventors: Alain Jouquey, Jean Salmon, Michel Mouren, Gaetan Touyer
  • Patent number: 4632820
    Abstract: Novel radioactive .DELTA..sup.4,9,11 -estratrienes marked with iodine 125 or 131 having the formula ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and acyl of an organic carboxylic acid of 2 to 12 carbon atoms, R.sub.1 is the reminder of an amino acid of the formula R.sub.1 NH.sub.2 or a derivative thereof being marked with iodine 125 or 131 and the wavy lines indicate the --OR is in the .alpha.- or .beta.-position and the oximido group is in the syn or anti position, a process and intermediates for their preparation, antigens prepared therefrom and use thereof to prepare antibodies.
    Type: Grant
    Filed: December 12, 1983
    Date of Patent: December 30, 1986
    Assignee: Roussel Uclaf
    Inventors: Alain Jouquey, Gaetan Touyer, Jean Salmon, Michel Mouren